Sanofi gets rated buy today, agreeing with bullish ratings from the Wall Street and SA analysts' consensus. With a diverse ...

Sanofi (SNY) has released an update ... TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know ...

View upcoming earnings forecasts and in-depth analysis of company forecasts.

Novavax has made a smaller splash in the U.S. Covid-19 vaccine market than it had hoped. But it's betting on licensing deals ...

Sanofi is scheduled to report results for the third quarter on ... Dow Jones Newswires Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers ...

Sanofi (NASDAQ:SNY – Free Report) by 30.4% during the third quarter, according to the company in its most recent filing with ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced ...

Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab ... will be presented in 23 abstracts at ...

Vir Biotechnology, Inc. ( (VIR) ) has released its Q3 earnings. Here is a breakdown of the information Vir Biotechnology, Inc. presented to its ...

Yuichi Iwaki, M.D., Ph.D., MediciNova CEO commented, “The successful resolution of the Sanofi-Novartis litigation and the resulting monetary damages due to MediciNova both validates the value of our ...

Yet, the company’s plans to open financial centers in new and existing ... research report on SAP here >>>) Other noteworthy reports we are featuring today include Boston Scientific Corp. (BSX), ...